CIDRAP newsletters options
The latest CDC steps provide a bridge to when vaccines will be widely available.
The findings may be related to living and working conditions and other factors.
Though it's an observational study and can't prove cause and effect, it holds promise.
"You've got to stick with this or your health system won't be able to cope."
While younger adults with no underlying health conditions have been considered safer from COVID-19's severe outcomes, of those who were hospitalized, 22% were admitted to intensive care units (ICUs), 10% needed mechanical ventilation, and 0.6% (3 patients) died, reports a study published yesterday in Clinical Infectious Diseases.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Two extensively drug-resistant strains of Klebsiella pneumoniae identified in two patients at an Italian hospital in May appear to be a dangerous variant of a strain that caused an outbreak in Tuscany in 2018 and 2019, Italian scientists reported yesterday in Eurosurveillance.
The vast majority of Europeans remain susceptible to surges in cases, a WHO official says.
About 30% of both pediatric and adult household contacts tested positive for COVID-19.
CDC Director Redfeld says the next few months will be "the most difficult in the public health history of this country."
Neither remdesivir, hydroxychloroquine, lopinavir, nor interferon-beta-1a—prevented death or other serious outcomes.
A year after the 2014 Ebola outbreak in Boende, Democratic Republic of the Congo, 22.5% of healthcare workers (HCWs) had Ebola virus (EBOV) antibodies in their blood, even though only 15.1% reported contact with suspected, probable, or confirmed Ebola virus patients, according to a study today in The Journal of Infectious Diseases.
A Sri Lankan analysis of global COVID-19 intervention measures showed that increased testing had the greatest impact on transmission: a 10-fold increase in the ratio of tests to new cases (TCR) reduced a country's average transmission by 9%. The study authors suggest that intense testing combined with isolation may be the most effective and least costly strategy for controlling COVID-19.
The CDC advises 10 days of quarantine with no symptoms and 7 days if no symptoms and a negative test.
The UK becomes the first country in the world to approve a COVID-19 vaccine for emergency use.
An outbreak of carbapenem-resistant Acinetobacter baumannii happened after some control steps were altered.
Telephone consultations could be the reason why antibiotic prescribing at general practices in the United Kingdom was higher than expected during the first COVID-19 lockdown, researchers with the University of Nottingham reported yesterday in the Lancet Infectious Diseases.
A New England Journal of Medicine study yesterday of cancer patients with COVID-19 demonstrated viral RNA shedding for up to 78 days and live virus for up to 61 days, suggesting extended infectiousness in patients whose immune system is suppressed.
The report calls for increased transparency on vaccine and treatment development and meeting states' needs for scarce medical supplies.
The experts also raised the possibility that, for the next phase, essential workers could be placed ahead of seniors and those with underlying conditions as a way to prioritize people of color, who have higher risk.
